Acquisition of a U-Rhythm Device for Endocrine and Metabolic Investigation
ID: 75N94024Q00266Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NICHDBETHESDA, MD, 20817, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/2a7ccc0e3cd64c4285b3034c71585a77/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the acquisition of a U-Rhythm device intended for endocrine and metabolic research at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The procurement aims to obtain U-RHYTHM microdialysis collection devices, which are crucial for monitoring hormone levels in interstitial tissue fluid over extended periods in real-world settings, and includes essential components such as a portable syringe pump, microdialysis catheter, tubing assemblies, and processing kits. This equipment is vital for advancing scientific understanding and treatment options in endocrine and metabolic health. Interested vendors should contact Amber Harris at amber.harris@nih.gov for further details, as the solicitation is not set aside for small businesses and will be evaluated based on technical compliance and cost, with a Firm-Fixed Price purchase order to be delivered and accepted at the NIH facility in Bethesda, Maryland.

    Point(s) of Contact
    Amber Harris
    amber.harris@nih.gov
    Files
    Title
    Posted
    75N94024Q00266.Combined Synopsis Solicitation.pdf
    The document is a Combined Synopsis/Solicitation for the acquisition of a U-Rhythm device intended for use in endocrine and metabolic research at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The solicitation, numbered 75N94024Q00266, requests quotes for commercial items and is not set aside for small businesses. The objective is to procure U-RHYTHM microdialysis collection devices, essential for monitoring hormone levels in interstitial tissue fluid over extended periods in real-world settings. Required product features include a portable syringe pump linked to a microdialysis catheter and additional components such as tubing assemblies and processing kits. The proposal evaluation criteria emphasize technical compliance with specifications, while also considering cost. The purchase order will be a Firm-Fixed Price type, with payment upon delivery and acceptance at the NIH facility in Bethesda, Maryland. The document outlines requirements for vendor submissions, responsibilities regarding invoicing through the Invoice Processing Platform (IPP), and various Federal Acquisition Regulation (FAR) clauses applicable to the contract. By addressing these needs, the solicitation aims to support vital research in endocrine and metabolic health for enhanced scientific understanding and treatment options.
    Lifecycle
    Title
    Type
    Acquisition of a U-Rhythm Device for Endocrine and Metabolic Investigation
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Gore Medical branded stents (Brand Name restriction)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, National Institutes of Health seeks to procure specific medical devices for use in interventional radiology procedures. These are brand-restricted items, with the National Institute of Health specifying Gore Medical branded stents. The scope of work involves supplying several variants of two medical devices: Viatorr Tips Endo CX and Viabahn BX Balloon Expander Endo. The Viatorr Tips are measured in millimeters and vary in length, while the Viabahn BX Balloon Expanders are used in catheterization procedures. The medical devices are intended for minimally invasive procedures. The bill of materials provided outlines the exact models and quantities sought. Offerors must provide the following: 1 unit of Model PTB8105275, ID 00733132635016 - 8-10mmX5cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8107275, ID 00733132635030 - 8-10mmX7cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8108275, ID 00733132635047 - 8-10mmX8cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model BXB083901A, ID 00733132658718 - 8MMX39MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO 1 unit of Model BXB085901A, ID 00733132658732 - 8MMX59MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO Eligible applicants should be well-established surgical and medical instrument manufacturers (NAICS code 339112) with the ability to deliver the specified devices promptly. The evaluation of quotes will consider technical capability, price, and past performance. Quotes should be submitted to Lu Chang at lu-chang.lu@nih.gov by 5:00 PM EST on 08/01/2024, including the RFQ number (RFQ-CC-24-010258) in the subject line. Further inquiries can be directed to the same email address. This opportunity is a combined synopsis and solicitation issued under FAR Subpart 12.6. The resulting contract will be a firm fixed-price order.
    CYTEK AURORA 5 LASER WITH LOADER - UV/V/B/YG/R - PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a premium service agreement for a Cytek Aurora 5 laser with loader, which is essential for advanced laboratory applications. The procurement includes comprehensive maintenance services, such as preventive inspections, technical support, and on-site assistance, ensuring optimal functionality of the equipment throughout the contract period from December 1, 2024, to November 20, 2025. This acquisition is critical for supporting the NIH's research initiatives in allergy and infectious diseases, emphasizing the importance of reliable laboratory equipment and services. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 13, 2024, at 12:00 am EST, and can contact Maliaka Pinkney or Jesse D Weidow for further inquiries.
    Preventative Maintenance Agreement for Sciex Triple Quad 6500 Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to establish a Preventative Maintenance Agreement for two Sciex Triple Quad 6500 Systems utilized by the Department of Laboratory Medicine at the NIH Clinical Center. This contract aims to ensure optimal performance through annual preventative maintenance and timely repairs, which are critical for maintaining uninterrupted laboratory services for both clinical and research purposes. The selected vendor, Ab Sciex LLC, is the sole manufacturer of the equipment and will provide comprehensive coverage under the Sciex Assurance and Software Plus Plans, ensuring access to OEM parts and software support for a period from December 22, 2024, to December 21, 2027. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 8, 2024, at 6:30 AM EST, as this is not a request for proposal and the total contract value will not exceed $250,000.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Investment
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole-source contract for consulting services related to medical device development under the Blueprint MedTech Initiative. The objective is to procure a subject matter expert with extensive experience in neurotechnology and mental health product development, who will provide technical guidance and strategic oversight as a member of the Blueprint MedTech External Oversight Committee. This initiative, established in 2019 with a budget of $32 million, aims to facilitate the transition of innovative neurotechnologies to clinical studies, addressing the challenges faced by innovators in the medical device sector. Interested parties may express their capabilities, but the decision to proceed with competition remains at the government's discretion. For inquiries, contact Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov, both reachable at 301-443-6677.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Research and Development
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), intends to award a sole source contract to Luminescent Consulting LLC for consulting services related to medical device development under the Blueprint MedTech Initiative. The objective of this procurement is to secure a subject matter expert with at least 20 years of experience in medical device development, including a minimum of 10 years in a Program Director role, to provide strategic guidance and feedback on projects aimed at advancing translational neurological medical device technologies. This initiative, which has allocated $32 million from 2019 to 2027, seeks to facilitate the transition of innovative medical technologies from early development to clinical trials, with a goal of conducting at least ten first-in-human studies. Interested parties may submit capability statements by November 8, 2024, to Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov, although the government is not obligated to enter into a competitive procurement process.
    Relocation of Sartorius CompacT SelecT (Annapurna) for decommissioning, and relocation of CompacT SelecT (Quartz) to NCATS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking a qualified vendor to facilitate the relocation and decommissioning of two Sartorius CompacT SelecT systems, specifically the Annapurna and Quartz models, as part of a sole source contract with Sartorius Stedim North America Inc. The project involves two phases: first, disassembling the Annapurna system for storage at the National Center for Advancing Translational Sciences (NCATS), and second, preparing the Quartz system for disassembly, transport, and recommissioning at NCATS. This procurement is critical for ensuring the safe transfer and management of specialized scientific equipment essential for NIH's medical research initiatives. Interested parties must submit their capabilities and proposals by November 6, 2024, to Patricia da Silva at patricia.dasilva@nih.gov, with the contract expected to commence in February 2025.
    Sources Sought Rees Scientific Environmental Monitoring Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking qualified contractors to provide validation, calibration, and preventative maintenance services for the Rees Scientific Environmental Monitoring/Alarm System at the Clinical Center's Center for Cellular Engineering in Bethesda, Maryland. The contractor will be responsible for ensuring compliance with regulatory standards by monitoring critical environmental parameters such as temperature, humidity, and gas levels in facilities that manufacture cell and gene therapies for clinical trials. This initiative is crucial for maintaining high standards in clinical research environments and ensuring the integrity of sensitive biological materials. Interested parties must submit their responses by email to Sheri Eiri at sheri.eiri@nih.gov by 12:00 PM EST on November 7, 2024, and must be registered in the System for Award Management (SAM) to be eligible for consideration.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Investment Development
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA), intends to award a sole-source contract for consulting services related to medical device development under the Blueprint MedTech Initiative. The objective is to procure a subject matter expert with extensive experience in neurotechnology and mental health product development, who will provide strategic guidance and oversight for projects aimed at accelerating the translation of innovative medical devices for neurological disorders. This initiative, established in 2019 with a funding allocation of $32 million, seeks to facilitate the development of groundbreaking technologies and ensure their progression to clinical studies by 2027. Interested parties may submit their qualifications by November 8, 2024, to the designated contacts, Tracy Cain and Llakim Dubroff, at the NIH.